Trade Summary

6 days ago, Malik Fady Ibraham, serving as EVP Research, Development at Cytokinetics Inc (CYTK), sold 12,033 shares at $62.15 per share, for a total transaction value of $747,851.00. Following this transaction, Malik Fady Ibraham now holds 153,902 shares of CYTK.

This sale represents a 7.00% decrease in Malik Fady Ibraham's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 17, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 18, 2026, 1 day after the trade was made.

Cytokinetics Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.